コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 thral valve (AUV) is a rare but a well-known congenital anomaly.
2 Consanguinity is a major risk factor for congenital anomaly.
3 ionnaire data were available, 386 (3%) had a congenital anomaly.
4 h or without cleft palate (CL/P) is a common congenital anomaly.
5 niopagus (joined at the cranium) have a rare congenital anomaly.
6 trell (POC) is an extremely rare and complex congenital anomaly.
7 ncluding abortion, fetal death in utero, and congenital anomalies.
8 no additional chronic medical conditions or congenital anomalies.
9 ths, elective terminations, stillbirths, and congenital anomalies.
10 posure to omalizumab, including incidence of congenital anomalies.
11 ysis of the facial nerves and variable other congenital anomalies.
12 on to the risk for a range of specific major congenital anomalies.
13 ts born before 27 weeks of gestation without congenital anomalies.
14 is characterized by developmental delay and congenital anomalies.
15 y conotruncal heart defects (CTDs) and other congenital anomalies.
16 rt of subjects with developmental delays and congenital anomalies.
17 es the incidence of these often debilitating congenital anomalies.
18 egistered by EUROCAT, a European Registry of Congenital Anomalies.
19 s9 gene-edited mouse model revealed multiple congenital anomalies.
20 to 2.83 for 0.50+ Gy) was related to risk of congenital anomalies.
21 ndrome characterized by red cell aplasia and congenital anomalies.
22 frequency of hematological abnormalities and congenital anomalies.
23 ed by obesity, retinopathy, polydactyly, and congenital anomalies.
24 weight, neurological status, and presence of congenital anomalies.
25 xencephaly and spina bifida, important human congenital anomalies.
26 are CNVs within patients exhibiting multiple congenital anomalies.
27 syndrome, which is associated with multiple congenital anomalies.
28 terized by pediatric bone marrow failure and congenital anomalies.
29 d in individuals with mental retardation and congenital anomalies.
30 acterized by bone marrow failure and complex congenital anomalies.
31 a better understanding for the mechanism of congenital anomalies.
32 atric abnormalities, dysmorphic features and congenital anomalies.
33 of 788 patients with mental retardation and congenital anomalies.
34 ple lineages and is often defective in human congenital anomalies.
35 ore importantly, how they are pathogenic for congenital anomalies.
36 wide application in screening patients with congenital anomalies.
37 Five infants (6%) had congenital anomalies.
38 rdevelopment of the mammary glands and other congenital anomalies.
39 lectual disability, facial dysmorphisms, and congenital anomalies.
40 a recognizable facial gestalt, and variable congenital anomalies.
41 ts discharged >42 weeks of gestation or with congenital anomalies.
42 ate condition that causes neurocognitive and congenital anomalies.
43 esolution in 273 subjects with a spectrum of congenital anomalies.
44 ing on two distinct outcomes: fetal loss and congenital anomalies.
45 th both neurodevelopmental and extra-cardiac congenital anomalies.
46 iant in FGFR1 in an individual with multiple congenital anomalies.
47 he most prevalent and heterogeneous group of congenital anomalies.
48 ied as harmful for fetal loss and eleven for congenital anomalies.
49 of long-term survival associated with major congenital anomalies.
50 fidence interval [CI] 1.03-1.85, p = 0.031), congenital anomalies (1.29, 95% CI 1.04-1.59, p = 0.019)
52 ers who gave birth to an infant with a major congenital anomaly (41508) between 1979 and 2010, with f
53 -86.3) in individuals born with at least one congenital anomaly, 89.5% (88.4-90.6) for cardiovascular
57 ether there is an increased risk of specific congenital anomalies after exposure to antiasthma medica
58 ective cohort analysis of validated cases of congenital anomalies among 4,699 children of 1,128 male
60 as no evidence of an increased risk of major congenital anomalies among pregnant women exposed to oma
61 is associated with seminal defects and with congenital anomalies and childhood cancers in offspring.
62 ival of individuals born with specific major congenital anomalies and examine the factors associated
64 anemia, bone-marrow erythroblastopenia, and congenital anomalies and is associated with heterozygous
65 s a recently recognized syndrome of multiple congenital anomalies and mental retardation and is the f
68 gest inverse association with mortality from congenital anomalies and respiratory, endocrine, and car
69 ccording to the European Concerted Action on Congenital Anomalies and Twins (EUROCAT) classification
70 the operative correction of this complicated congenital anomaly and can be safely performed by experi
72 sional who has received specific training in congenital anomalies, and (3) standardized physical exam
77 erstanding the causation and pathogenesis of congenital anomalies, and developing new methods for the
79 s the leading contributor to pregnancy loss, congenital anomalies, and in vitro fertilization (IVF) f
80 e characterized by defective erythropoiesis, congenital anomalies, and increased frequency of cancer.
81 est were spontaneous abortions, stillbirths, congenital anomalies, and neonatal death (serious advers
82 in include ingested foreign bodies, infected congenital anomalies, and perforated peptic ulcer diseas
83 a (CDH) is one of the most common and lethal congenital anomalies, and significant evidence is availa
84 d statistical power to detect differences in congenital anomalies, and the lack of assessment of card
85 e secondary palate is one of the most common congenital anomalies, and the multiple corrective surger
86 ter's experience, the presence of associated congenital anomalies, and the postoperative occurrence o
87 ariable modelling, presence of a non-cardiac congenital anomaly (aOR 5.17, 95% CI 1.9-14.1), abdomina
88 e (eg, valve cell and matrix pathobiology in congenital anomalies, aortic valve calcification, and mi
89 ng the categories of causes of infant death, congenital anomalies (APC = -7.87%), asphyxia-related co
95 Fetal interventions to diagnose and treat congenital anomalies are growing in popularity but often
98 highest in children of Pakistani origin, and congenital anomalies are the most common cause of death
99 posure: Live birth of an infant with a major congenital anomaly as defined by the European Surveillan
100 The workgroup considered 3 approaches for congenital anomalies assessment that have been developed
101 rome (SMS), a genomic disorder with multiple congenital anomalies associated with a 3.7 Mb heterozygo
103 ith IBD, the adjusted odds ratios of a major congenital anomaly associated with drug use were 0.82 (9
105 Kismet, result in a complex constellation of congenital anomalies called CHARGE syndrome, which is a
108 have an increased prevalence of extracardiac congenital anomalies (CAs) and risk of neurodevelopmenta
109 prenatal antiretroviral (ARV) exposures with congenital anomalies (CAs) in children born to human imm
111 extracted from the European Surveillance of Congenital Anomalies central database for 29 population-
112 evelopmental delay, intellectual disability, congenital anomalies, characteristic facial dysmorphic f
116 ed and 33,043 unaffected pregnancies and our congenital anomalies cohort contains 5,658 affected and
122 and unbalanced, in individuals with multiple congenital anomalies continue to be a valuable resource
123 Holoprosencephaly (HPE), a common human congenital anomaly defined by a failure to delineate the
124 ort study of all VLBW infants without severe congenital anomalies delivered in all hospitals in Calif
125 Information about children with at least one congenital anomaly, delivered between 1985 and 2003, was
126 e small for gestational age, stillbirth, and congenital anomalies did not differ significantly betwee
129 lso known as 22q11.2 deletion syndrome, is a congenital anomaly disorder characterized by craniofacia
130 syndromes (MPS) comprise a group of multiple congenital anomaly disorders characterized by webbing (p
132 as 22q11.2 deletion syndrome (22q11DS), are congenital-anomaly disorders caused by a de novo hemizyg
133 yndromes (MPSs) comprise a group of multiple-congenital-anomaly disorders characterized by webbing (p
134 , intrauterine growth restriction, and fetal congenital anomalies, either apparent at birth or later
137 ng 15 of 16 uroepithelial malignancies, five congenital anomalies, five urinary tract calculi, and 18
140 the ureteropelvic junction (UPJ) is a common congenital anomaly frequently associated with ureteral d
141 he data set included 76,249 registrations of congenital anomalies from 13 EUROmediCAT registries.
145 in care have improved the prognosis for some congenital anomaly groups and subtypes, but there remain
147 though infant survival of children born with congenital anomalies has improved for many anomaly types
148 esponsible for a condition known as multiple congenital anomalies-hypotonia-seizures syndrome 2.
151 th weight in an infant, preterm delivery, or congenital anomalies in an infant) (23.6% vs. 17.0%; dif
152 nhancer mediated transcription, and that the congenital anomalies in CHARGE syndrome are due to alter
153 Concerns persist about the risk of major congenital anomalies in children of women with inflammat
157 r human development: mutations in TBX3 cause congenital anomalies in patients with ulnar-mammary synd
158 ital anomalies, though there were four major congenital anomalies in the letrozole group versus one i
159 gestation contribute to the risk of selected congenital anomalies in the San Joaquin Valley of Califo
160 tube defects are among the most common major congenital anomalies in the United States and may lead t
168 al demise, prematurity, low birth weight and congenital anomaly) in HIV-infected pregnant women enrol
169 fetal demise, prematurity, low birth weight, congenital anomaly) in pregnant women living with HIV en
170 recessive disorder characterized by multiple congenital anomalies including craniofacial abnormalitie
171 cy leads to Mowat-Wilson syndrome, a complex congenital anomaly including intellectual disability, ep
172 otein 7, in CHARGE syndrome lead to multiple congenital anomalies, including craniofacial malformatio
173 intellectual disability (XLID) and multiple congenital anomalies, including craniofacial, musculoske
175 e, during, and early after fetal surgery for congenital anomalies, including repair of myelomeningoce
176 ocephalic primordial dwarfism and additional congenital anomalies, including retinopathy, thereby ext
177 needs for reconstruction of tissues lost in congenital anomalies, infections, trauma, or tumor resec
180 for families and health professionals when a congenital anomaly is detected, and will assist in plann
181 l abnormalities, intellectual disability and congenital anomalies, is caused by a 3.7-Mb duplication
184 bination of current pregnancy complications, congenital anomalies, maternal characteristics, and medi
185 nting diseases categories in trauma, cancer, congenital anomalies, maternal/reproductive health, agin
188 Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associate
189 Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associate
190 y was associated with a doubling of risk for congenital anomaly (multivariate RR 2.19, 95% CI 1.67-2.
193 nancy was associated with higher odds of any congenital anomaly (N=23,300, k=11; prevalence=4.1%, k=1
194 ls with neurodevelopmental presentations and congenital anomalies (ND/CAs), i.e., the analysis of seq
195 s) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and
196 e risk was also not significantly higher for congenital anomalies, neoplasm, or vision or hearing los
197 onatal death within 28 days of birth and any congenital anomaly, neoplasm, and hearing or vision loss
198 terized by intellectual disability, multiple congenital anomalies, obesity, neurobehavioral abnormali
199 9%; 170 babies), pregnancy complications and congenital anomalies occurred in 13 (11.6%) and 2 (1.8%)
201 servations: We reviewed published reports of congenital anomalies occurring in fetuses or infants wit
203 n several congenital diseases such as CAKUT (Congenital anomalies of kidney and urinary tract) and es
205 ptor tyrosine kinase RET are associated with congenital anomalies of kidneys or urinary tract (CAKUT)
206 sly shown to produce features reminiscent of congenital anomalies of kidneys or urinary tract (CAKUT)
209 c relationship with other urogenital organs, congenital anomalies of seminal vesicles may accompany o
210 imaging findings and clinical importance of congenital anomalies of seminal vesicles with images of
213 e VUJ, which are frequent in the spectrum of congenital anomalies of the kidney and the urinary tract
223 gnaling pathway are a major genetic cause of congenital anomalies of the kidney and urinary tract (CA
227 rotic syndrome (nine out of 21 individuals), congenital anomalies of the kidney and urinary tract (te
228 ctual disability, developmental delay and/or congenital anomalies of the kidney and urinary tract.
233 is heterogeneous and not uncommonly includes congenital anomalies of the mitral valve apparatus for w
237 Hirschsprung's disease (HSCR) is a severe congenital anomaly of the enteric nervous system (ENS) c
238 sicoureteral reflux (VUR) is the most common congenital anomaly of the kidney and the urinary tract,
241 lly valuable in analyses of stillbirths with congenital anomalies or in cases in which karyotype resu
243 fferences among groups in the frequencies of congenital anomalies or major fetal and neonatal complic
246 Infants were ineligible if they had major congenital anomalies or severe RDS requiring early intub
247 ry low certainty of evidence for the RCT) or congenital anomalies (OR 1.69 [95% CI 0.83-3.41] with ve
248 eporting on the safety (primary outcome, any congenital anomaly) or efficacy (primary outcome, mood r
251 vement in survival of children with specific congenital anomalies over the last few decades and predi
252 nt predictors of longer hospitalization were congenital anomaly (P<.0001), lower weight on admission
253 comprises premature birth, low-birth-weight, congenital anomalies, perinatal asphyxia, postsurgical,
254 inine and creatinine kinase levels, rates of congenital anomaly, premature birth, and growth paramete
256 tcomes of interest were perinatal mortality, congenital anomalies, preterm birth, postterm birth, sma
257 e risk of miscarriage, stillbirth, and major congenital anomaly (primary outcomes) among first-trimes
258 stability disorder characterized by multiple congenital anomalies, progressive bone marrow failure, a
259 t trend with radiation dose in the number of congenital anomalies recorded in offspring of female pat
260 ies central database for 29 population-based congenital anomaly registries in 16 European countries c
261 mal rearrangements in individuals with major congenital anomalies represent natural experiments of ge
262 underlying causes were identified, including congenital anomalies; respiratory, endocrine, cardiovasc
263 are not at significantly increased risk for congenital anomalies stemming from their parent's exposu
264 on of large segmental facial hemangiomas and congenital anomalies, such as posterior fossa malformati
265 Kabuki syndrome (KS) is a rare multiple congenital anomaly syndrome characterized by distinctive
267 of histone-modification enzymes in multiple-congenital-anomaly syndromes, and further illustrate the
268 and their offspring are more likely to have congenital anomalies than offspring in the general popul
270 also characterized by growth retardation and congenital anomalies that are present in approximately 3
271 rome of intellectual disability and multiple congenital anomalies that features generalized craniotub
272 ave important implications for understanding congenital anomalies that may be causative for adult-ons
273 ectal malformations are uncommon but complex congenital anomalies that require an individualised stra
274 rtery with an interarterial course is a rare congenital anomaly that carries an increased risk of sud
275 Craniofacial microsomia (CFM) is a rare congenital anomaly that involves immature derivatives fr
277 ) without significant differences in overall congenital anomalies, though there were four major conge
278 research on approaches to the assessment of congenital anomalies to better guide investigators in op
279 cable diseases, the relative contribution of congenital anomalies to child mortality is increasing.
282 41 studies (n = 54,676) investigating eight congenital anomaly types (spina bifida [n = 7,422], ence
284 among 41508 mothers of a child with a major congenital anomaly vs 10112 deaths (1.27 per 1000 person
285 in the EXPECT study, the prevalence of major congenital anomalies was 8.1%, which was similar to the
286 neous families in which a similar pattern of congenital anomalies was found to be most likely caused
288 nce: In Denmark, having a child with a major congenital anomaly was associated with a small but stati
289 whether birth of an infant born with a major congenital anomaly was associated with higher maternal r
294 akes this technology ideal for children with congenital anomalies who often require reconstructive pr
295 e notion that earlier surgical correction of congenital anomalies will lead to improved outcomes perm
296 egarding the optimal method of assessment of congenital anomalies will likely vary depending on the c
297 ylation and deacetylation result in multiple congenital anomalies with most individuals displaying si
298 way malformation (CPAM) is a relatively rare congenital anomaly with a wide spectrum of ultrasound fe
299 year of life) of children born with a major congenital anomaly with the follow-up starting from birt